Subject: Winter Rally of Small Stocks Continues Date: Published: 12/18/87 77 lines Source: WALL STREET JOURNAL. Copyright Dow Jones & Co. Inc. OTC Focus: Winter Rally of Small Stocks Continues, With Heavy Buying in Local Bank Issues --- By Priscilla Ann Smith Staff Reporter of The Wall Street Journal Speculators refused to stop their over-the-counter buying spree yesterday, as the winter rally in small stocks continued into its fourth day. As a result, OTC prices veered sharply from those of the exchange-listed blue chips, which tumbled. Heavy buying of smaller issues, particularly local bank and thrift stocks, pushed the Nasdaq composite index to 319.5, up 0.25 points, as the Dow Jones Industrials slid 50 points yesterday. Stocks with advancing prices on Nasdaq beat declining issues 5 to 4. Volume on the National Market System, where most of the speculation is taking place, swelled to 126 million shares, the rally's second post-crash record. Total volume on the National Association of Securities Dealers automated quotation service yesterday was 167 million shares, also a post-crash record. Prices among the giant technology issues favored by the largest institutions fell yesterday in line with prices of big exchange-listed issues. Microsoft was off 2 1/4 to 52, Lotus dropped 1 1/4 to 28 1/2, and Sun Microsystems fell 1 5/8 to 30 7/8. Apple Computer was unchanged at 39 1/4. The biggest Nasdaq retail and consumer issues slid yesterday as well. Liz Claiborne was off 1/2 to 15 1/4; Nordstrom fell 1 to 20. Among smaller stocks, however, a different story unfolded yesterday. Asset managers, concerned that the early winter rally might prevent the OTC market from going lower any time soon, started buying selected medium-sized issues, traders said. Often these professionals wait until year-end to buy their carefully-selected OTC stocks, when prices usually hit rock-bottom as other investors do tax-related selling. Thus, yesterday, Shorewood Packaging rose 7/8 to 10 1/2. The company has strong earnings growth and is already up in price about 90% for the year. Similarly, Dyatron, a software issue, rose 1 1/4 to 11 3/4; K Tron International was up 1 to 9 1/8; Commercial Shearing, an industrial issue, rose 2 to 13 7/8. Associated Communications Class B was up 3 to 21, on announcement of strong earnings gains. But most of yesterday's heavy buying was among depressed medium-sized and smaller stocks with prices down 30% to 60% for the year. Yesterday's most popular issues covered an expanding range of sizes -- from about $15 million in market value all the way to about $150 million. Among technology issues, Teredata, a computer stock, rose 1 3/4 to 14 1/2; Lancer rose 1 1/4 to 7; Davox was up 3/4 to 5 5/8. Among health-service issues Healthcare Compare rose 1 5/8 to 9 5/8; HMSS Inc. was up 1 1/8 to 13 1/2. Among drug and biotechnology stocks, Marsam Pharmaceuticals rose 1 to 9 1/4; Alpha 1 Biomedicals -- which announced a joint agreement to market its AIDS vaccine -- rose 1 to 9. Centrafarm Group said it might go private, sending its stock price up 2 1/2 to 10. As for smaller bank and thrift stocks, American Savings Financial of Tacoma, Wash., said it was approved for FDIC insurance, and its price rose 3 to 12; Commonwealth Savings & Loan of Florida rose 1 1/4 to 7 1/4, and Starpointe Savings Bank of Plainfield, N. J., rose 2 1/2 to 14 1/2. The Nasdaq bank index, which largely reflects prices of savings banks, rose 4.01 points, or 1.1%, to 379.07, outperforming all of the other Nasdaq indexes. [This article is made available here by Dow Jones Co. for the personal and non-commercial use of callers to this bbs, in the hope that it will be of some help to those who are suffering from the disease and others who are seeking to help them.]